The researchers believe that soya could enhance the combat against breast and prostate cancer. The prospective health benefits of soya have been emphasized through two researches. In one study, team of researchers from Northwestern University, Chicago revealed that one pill of genistein, which is natural occurring isoflavone chemical in soya daily, appeared to slow or halt the spread of prostate cancer.
While, it was tested on a small group of thirty-eight males, the researcher told that the outcomes could escort to foremost non-toxic treatment which prevents movements of cancer cells. The second study was carried out over nearly thirteen hundred women by research team from the University at Buffalo, New York.
The results of the study showed that isoflavones from soya can diminish the threat of developing breast cancer in women. The study author Anne Weaver revealed that women who consumed highest isoflavone had a thirty percent lower threat of an invasive breast tumour and had lower threat low-grade tumour by up to sixty percent.
To find out the results the team lead by Ms Weaver analyzed nearly seven hundred women suffering breast cancer and compared them those with more than six hundred healthy women. She stated the like most dietary studies, those finding were not ultimate and required to be measured in the context of more follow-up and corroboration.
The initial stride is to observe if the drug has the effect one wants on cells and the prostate. Whether the drug can halt the moving of prostate cancer in the body, hypothetically an analogous remedy could have the same effect on the cells of other cancers, explained Prof Raymond Bergan.
This could be the first therapy for any cancer that is non-toxic, targets and holds back cancer cell movement, added Prof Bergan.